News

FDA Abbott Supera Self-Expanding Stent Peripheral Artery Disease

The U.S. Food and Drug Administration (FDA) approved Abbott’s Supera Peripheral Stent System to treat people with blocked blood vessels in the upper leg caused by peripheral artery disease (PAD...

The U.S. Food and Drug Administration (FDA) cleared Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial...

Cordis Trieme Chocolate PTA Balloon Catheter Peripheral Artery Disease PAD

Cordis Corp. announced an agreement with TriReme Medical Inc. that grants the company exclusive distribution rights for the Chocolate PTA Balloon Catheter. 

February 28, 2014 — Mercator MedSystems released pilot study data from a single-arm, open label study of 20 patients suffering with peripheral artery disease (PAD), which reveal sustained,...

Medtronic Total Across Crossing Catheter CTO Peripheral Artery Disease PAD

Medtronic Inc. launched in Europe its Total across crossing catheter. Total received CE marking for improving blood...

Boston Scientific OffRoad Re-Entry Catheter System CTO PAD Cath Labs

Boston Scientific launched in the United States the OffRoad Re-Entry Catheter System to treat complete arterial...

AtheroMed Phoenix Atherectomy System Device Peripheral Artery Disease PAD

AtheroMed, a developer of catheter technologies for treating ...

Bard Drug Coated Balloon Below the Knee Clinical Trial Peripheral Artery Disease

Experts presented six-month LEVANT 2 trial results for C. R. Bard Inc.’s Lutonix drug coated balloon (DCB) and provided updates on the ongoing Lutonix Below the Knee (BTK) Clinical Trial...

Espirt Bioresorbable Vascular Scaffold BVS Peripheral Artery Disease PAD

Six-month results of the ESPRIT trial suggest a bioresorbable drug-eluting scaffold is effective in opening...

balloon catheters peripheral artery disease intact vascular tack-it

Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced the start of enrollment in the Tack Optimized ...

stents peripheral clinical triady study S.M.A.R.T. nitinol stent cordis

Researchers at Saint Luke’s Mid America Heart Institute led a study that showed marked, long-term improvement...

bard, DEB, drug eluting balloon

The first clinical trial in the United States to study the use of drug-coated ...

October 23, 2013 — Vascular Interventional Advances (VIVA) Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...

stents peripheral artery disease pad devices fda lifestent solo vascular bard

Bard Peripheral Vascular has sent an urgent Class I medical device recall notification letter informing customers of the problems of the LifeStent Solo ...

stents peripheral atherectomy devices artery disease PAD covidien everflex

Covidien released positive final results from its Durability II study and promising preliminary data from its Definitive AR trial at the Vascular Interventional Advances (VIVA) 2013 conference in...

OffRoad, CTO, OffRoad CTO Device, Boston Scientific

 The Boston Scientific OffRoad Re-Entry Catheter System demonstrated excellent performance in facilitating the treatment of complete blockages in the major arteries that supply blood to the...

stents peripheral peripheral artery disease pad clinical trial study bioflex

Biotronik announced it has completed patient enrollment in the iliac arm of its Bioflex-I trial. Under the supervision of Mark Burket, M.D. and chief, Cardiovascular Division at the University of...

stent peripheral artery disease treatment complete se medtronic

Expanding its role in the treatment of peripheral artery disease in the United States, Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Complete...

Avinger Inc. has received CE Mark approval for Pantheris – a system that combines directional atherectomy capabilities with real-time intravascular visualization to remove plaque from blocked...

August 28, 2013 — Effective Oct. 1, Cook Medical’s Zilver PTX drug-eluting peripheral stent qualifies for new-technology add-on payments under Medicare’s hospital inpatient prospective...